Robert Redfield, director of the Centers for Disease Control and Prevention, speaks during a July 31 House Select Subcommittee hearing on the coronavirus.

Robert Redfield, director of the Centers for Disease Control and Prevention, speaks during a July 31 House Select Subcommittee hearing on the coronavirus. Erin Scott/Pool via AP

Coronavirus Roundup: CDC Director Clarifies New Testing Guidance; IRS Expands Use of Electronic Signatures 

There's a lot to keep track of. Here’s today’s list of news updates and stories you may have missed.

For over five months now, many employees (who are able) have been working from home. General Services Administration Administrator Emily Murphy shared on Friday what she’s telling her employees. “Take breaks from work to stretch, take a walk, exercise, or check-in with coworkers, family, and friends,” she said. “Spend time outdoors, get fresh air, and step away from the computer!” Here are some other recent headlines you might have missed. 

On Thursday, Sens. Bob Casey, D-Pa.; Ron Wyden, D-Ore.; and Elizabeth Warren, D-Mass., wrote the Food and Drug Administration and Centers for Medicare and Medicaid Services with concerns about the use of the anti-malaria drug hydroxychloroquine in nursing homes to treat the coronavirus, despite no evidence proving its effectiveness and revised guidance from the FDA. President Trump is still advocating for using the drug, so the “mixed messaging from the administration coupled with an absence of clear guidance, has led to the drug’s continued use, even after the FDA issued warnings about its safety,” the senators wrote. They also wrote to the Health and Human Services Department inspector general to request an investigation. 

Centers for Disease Control and Prevention Director Dr. Robert Redfield clarified the change in coronavirus testing guidance earlier this week that caused much backlash. “Everyone who needs a COVID-19 test, can get a test. Everyone who wants a test does not necessarily need a test,” he said. “The key is to engage the needed public health community in the decision with the appropriate follow-up action.” He also said “all close contacts of confirmed or probable COVID-19 patients,” can get tested. However, the CDC didn’t change its website after the director released the statement, NBC News reported on Thursday. 

On Thursday, five House Democrats asked the CDC to explain how and why officials changed the guidance. The lawmakers said that it is “counterproductive” not to test asymptomatic individuals and asked detailed questions on the White House’s involvement. 

The CDC and Homeland Security Department are considering a plan to collect phone numbers and email addresses from all incoming air travelers to the United States (including American citizens), as part of a contact tracing plan, NBC News reported on Thursday. The program is “intended to allow airlines to alert travelers who may have come in contact with an infected passenger,” said the report. However, “two sources with knowledge of the program say the information could be accessed by law enforcement agencies, including Immigration and Customs Enforcement, and potentially used to track the arriving air travelers.” 

The CDC is seeking public comment on a proposed rule that would require cruise ship operators to submit plans to the CDC, HHS and/or Coast Guard that outline how they will prevent coronavirus outbreaks onboard. “If unrestricted cruise ship passenger operations are permitted to resume after the March 14, 2020, ‘No Sail Order,’ infected and exposed cruise ship cases would place health care workers at substantial increased risk,” said a notice in the Federal Register published on Friday. “Specifically, these cases would divert medical resources away from persons with other medical problems and other COVID-19 cases, consuming precious diagnostics, therapeutics and protective equipment.” Feedback is due by October 27. 

The Federal Emergency Management Agency doesn’t “have any limiting factors at this point” in the response to Hurricane Laura amid the use of FEMA funds for unemployment payments, as outlined in the president’s recent executive order after Congress failed to negotiate a deal on a new economic stimulus package. “FEMA has sufficient resources to handle” the hurricane and the payments, David Bibo, acting associate administrator for the agency’s Office of Response and Recovery, said on a press call on Thursday. 

President Trump delivered his Republican convention acceptance from the White house lawn on Thursday night in front of a crowd of over 1,000, despite the fact that Washington, D.C.’s phase two reopening guidelines prohibit gatherings of over 50 people. Masks were not required and "a number of" guests at the White House were tested, but "you make choices individually," said Chief-of-Staff Mark Meadows. "I'm not worried about that based on the protocols that we have in place,” Meadows said, according to an NBC News report. Members of the president’s Cabinet sat in the front row and it appeared that HHS Secretary Alex Azar was the only one wearing a mask. Read Government Executive’s full coverage of the speech here

The Internal Revenue Service announced on Friday it would accept electronic signatures for certain forms from now until the end of the year to reduce personal contact. "We take the health and safety of the nation's taxpayers, the tax professional community and our employees very seriously," IRS Commissioner Chuck Rettig said. “We will continue to review our processes to determine where long-term actions can help reduce burden for the tax community, while appropriately balancing that with critical security and protection against identity theft and fraud."

Two senior public relations officials were removed from the FDA following a messaging mishaps about its authorization of convalescent plasma and the data on the treatment. One was Emily Miller, the chief agency spokeswoman, who was on the job only 11 days. The other was a consultant who advised FDA Commissioner Dr. Stephen Hahn. However, HHS denied there was a connection between the cancelation of the consultant's contract and the plasma situation, The New York Times reported on Friday. 

On Friday, the Veterans Affairs Department announced it will begin a new clinical trial on convalescent plasma treatment for veterans with coronavirus. It plans to enroll 700 veterans who are hospitalized at VA medical centers. The FDA gave emergency use authorization for the treatment earlier this week and “stresses further evidence from rigorous trials—such as the new VA study—is ‘critically important’ for establishing safety and efficacy,” VA stated.

Today’s GovExec Daily podcast episode features a former FEMA official and emergency management veteran discussing how the agency can manage Hurricane Laura disaster relief during the pandemic. 

Help us understand the situation better. Are you a federal employee, contractor or military member with information, concerns, etc. about how your agency is handling the coronavirus? Email us at newstips@govexec.com.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.